Senior insider sale
Chief Medical Officer at UNIQURE N.V. — senior position signals high conviction
$2.59M
76.43K shares
What this filing means
ABI-SAAB WALID plans to sell 76.43K shares of UNIQURE N.V. valued at approximately $2.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001973379-26-000261
Officer· Chief Medical Officer
Since Mar 2026
76.43K
Shares to sell
$2.59M
Approx. market value
30K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Stock option exercise pursuant to 10b51 plan
Cash
6/30/2026
10KVested shares resulting from restricted Stock Vesting
COMPENSATION
6/26/2025
20KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Stock option exercise pursuant to 10b51 plan Cash | 10K | — |
6/26/2025 | Vested shares resulting from restricted Stock Vesting COMPENSATION | 20K | — |
| Total | 30K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.43K
Market value
$67.2K
6/26/2026
—Completed
Units to sell
45K
Market value
$1.13M
5/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$1.39M
6/30/2026
Total
Units
76.43K
Value
$2.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2026 | 1.43K | $67.2K | — | Completed |
5/8/2026 | 45K | $1.13M | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 30K | $1.39M | NASDAQ | Planned |
| Total | 76.43K | $2.59M | ||